{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:33:46Z","timestamp":1772069626565,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6494,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1038\/modpathol.3800300","type":"journal-article","created":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T16:03:58Z","timestamp":1097251438000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Ezrin in primary cutaneous melanoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Suvi","family":"Ilmonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Vaheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Asko-Seljavaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Carpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3800300_bib1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional area, and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"10.1038\/modpathol.3800300_bib2","unstructured":"Balch CM, Houghton AN, Sober AJ, et al. Cutaneous Melanoma, 4th edn. Quality Medical Publishing: St. Louis, MO, 2003."},{"key":"10.1038\/modpathol.3800300_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/sonc.2002.34116","article-title":"Pathologic staging of melanoma","volume":"29","author":"Ruiter","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.3800300_bib4","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800300_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","article-title":"An evidence-based staging system for cutaneous melanoma","volume":"54","author":"Balch","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.3800300_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0733-8635(02)00027-X","article-title":"Prognostic factors","volume":"20","author":"Rogers","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1038\/modpathol.3800300_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1038\/modpathol.3800300_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000658-198808000-00004","article-title":"Lethal \u2018thin' malignant melanoma. Identifying patients at risk","volume":"208","author":"Slingluff","year":"1988","journal-title":"Ann Surg"},{"key":"10.1038\/modpathol.3800300_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(19860201)57:3<545::AID-CNCR2820570323>3.0.CO;2-K","article-title":"Recurrence potential of thin malignant melanoma","volume":"57","author":"Naruns","year":"1986","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800300_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00000372-200206000-00016","article-title":"Immunohistochemical markers of melanocytic lesions","volume":"24","author":"Mangini","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/modpathol.3800300_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-0560.2002.290602.x","article-title":"New prognostic factors of cutaneous melanoma: a review of the literature","volume":"29","author":"Li","year":"2002","journal-title":"J Cutan Pathol"},{"key":"10.1038\/modpathol.3800300_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/106689690301100103","article-title":"Immunohistochemical markers of melanocytic tumors","volume":"11","author":"Yaziji","year":"2003","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/modpathol.3800300_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/cncr.11250","article-title":"Diagnostic value and prognostic significance of protein S-100\u03b2, melanoma-inhibitory activity, and tyrosinase\/MART-1 reverse transcription-polymerase chain reaction in the folllow-up of high-risk melanoma patients","volume":"97","author":"Garbe","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800300_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0190-9622(96)90607-6","article-title":"MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma","volume":"35","author":"B\u00f6ni","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/modpathol.3800300_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2559.1996.d01-558.x","article-title":"p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin","volume":"30","author":"Vogt","year":"1997","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3800300_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1523-1747.ep12312431","article-title":"Mib-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas","volume":"105","author":"Ramsay","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.3800300_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cncr.10685","article-title":"Evaluation of the proliferation marker Mib-1 in the prognosis of cutaneous malignant melanoma","volume":"95","author":"Hazan","year":"2002","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800300_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.273.1.1","article-title":"The p53 network","volume":"273","author":"Agarwal","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800300_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.1994.76","article-title":"The 1993 Walter Hubert Lecture: the role of the p53 tumor-suppressor gene in tumorigenesis","volume":"69","author":"Levine","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800300_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1995.tb02487.x","article-title":"Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications","volume":"133","author":"Weiss","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.3800300_bib21","first-page":"25","article-title":"Immunocytochemical evaluation of proliferating cell nuclear antigen, Ki-67 (Mib-1), and p53 in predicting survival of primary and metastatic malignant melanomas","volume":"4","author":"Stone","year":"1996","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.3800300_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000372-199502000-00002","article-title":"Bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi","volume":"17","author":"Cerroni","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/modpathol.3800300_bib23","first-page":"150","article-title":"Bcl-2 protein expression in melanocytic neoplasms of the skin","volume":"8","author":"Ramsay","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3800300_bib24","first-page":"294","article-title":"Bcl-2 expression in human melanocytes and melanocytic tumors","volume":"145","author":"van den Oord","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3800300_bib25","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1002\/j.1460-2075.1989.tb08598.x","article-title":"cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1","volume":"8","author":"Gould","year":"1989","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.3800300_bib26","doi-asserted-by":"crossref","first-page":"16727","DOI":"10.1016\/S0021-9258(19)84765-8","article-title":"Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization","volume":"264","author":"Turunen","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800300_bib27","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1242\/jcs.110.24.3011","article-title":"Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures","volume":"110","author":"Bretscher","year":"1997","journal-title":"J Cell Sci"},{"key":"10.1038\/modpathol.3800300_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0955-0674(97)80154-8","article-title":"ERM (ezrin\/radixin\/moesin) family: from cytoskeleton to signal transduction","volume":"9","author":"Tsukita","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0955-0674(97)80119-6","article-title":"The ezrin protein family: membrane\u2013cytoskeleton interactions and disease associations","volume":"9","author":"Vaheri","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0955-0674(99)80013-1","article-title":"Regulation of cortical structure by the ezrin\u2013radixin\u2013moesin protein family","volume":"11","author":"Bretscher","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1083\/jcb.126.6.1445","article-title":"Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family","volume":"126","author":"Turunen","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib33","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1073\/pnas.96.13.7300","article-title":"Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase\/Akt pathway","volume":"96","author":"Gautreau","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800300_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/emboj\/16.1.35","article-title":"Ezrin is a cyclic AMP-dependent protein kinase anchoring protein","volume":"16","author":"Dransfield","year":"1997","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.3800300_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1083\/jcb.138.4.927","article-title":"Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin\/radixin\/moesin proteins","volume":"138","author":"Mackay","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.LAB.0000098425.03006.42","article-title":"Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin","volume":"83","author":"Lugini","year":"2003","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.3800300_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/nbdi.1997.0128","article-title":"Molecular insights into neurofibromatosis 2","volume":"3","author":"Gutmann","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1038\/modpathol.3800300_bib38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0002-9440(10)64816-X","article-title":"Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumours but is absent in oligodendrogliomas","volume":"157","author":"Geiger","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3800300_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm966","article-title":"Expression profiling identifies cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as a key metastatic regulators","volume":"10","author":"Yu","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.3800300_bib40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nm982","article-title":"The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis","volume":"10","author":"Khanna","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.3800300_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0090-8258(03)00262-2","article-title":"Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients","volume":"90","author":"Moilanen","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3800300_bib42","first-page":"2422","article-title":"Ezrin as a prognostic indicator and its relationship to tumour characteristics in uveal malignant melanoma","volume":"42","author":"M\u00e4kitie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/modpathol.3800300_bib43","first-page":"367","article-title":"Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumours","volume":"148","author":"B\u00f6hling","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3800300_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molmed.2004.03.001","article-title":"Ezrin, a key component in tumor metastasis","volume":"10","author":"Hunter","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1038\/modpathol.3800300_bib45","first-page":"1127","article-title":"\u03b12\u03b21 integrin signaling via the mitogen activated protein kinase pathway modulated retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity","volume":"13","author":"Vo","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1038\/modpathol.3800300_bib46","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1101\/gad.242602","article-title":"CD44 is required for two consecutive steps in HGF\/c-Met signaling","volume":"16","author":"Orian-Rousseau","year":"2002","journal-title":"Genes Dev"},{"key":"10.1038\/modpathol.3800300_bib47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1083\/jcb.138.2.423","article-title":"Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells","volume":"138","author":"Crepaldi","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1038\/modpathol.3800300_bib48","first-page":"1576","article-title":"Hepatocyte growth factor\/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1","volume":"63","author":"Recio","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800300_bib49","first-page":"3728","article-title":"Mitogen-activated protein kinase activation is an early event in melanoma progression","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.3800300_bib50","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1073\/pnas.052707699","article-title":"Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase","volume":"99","author":"Koo","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800300_bib51","first-page":"5669","article-title":"Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade","volume":"63","author":"Collisson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800300_bib52","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2133.1998.02255.x","article-title":"Moesin and CD44 expression in cutaneous melanocytic tumours","volume":"138","author":"Ichikawa","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.3800300_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3835(01)00857-6","article-title":"Ezrin, a membrane\u2013cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma","volume":"179","author":"Ohtani","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1038\/modpathol.3800300_bib54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1999.0653","article-title":"High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential","volume":"258","author":"Akisawa","year":"1999","journal-title":"Biochem Biophys Res Commun"}],"updated-by":[{"DOI":"10.1038\/modpathol.3800429","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000}}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3800300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800300","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222046567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222046567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T04:26:34Z","timestamp":1676262394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222046567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0893395222046567"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3800300","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezrin in primary cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3800300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3800429","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}